UNSPSC 51271621: Bumecaine hydrochloride

This classification denotes an anesthetic agent C18H28N2O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PBE1H9OIFQ, chemically known as 1-butyl-2',4',6'-trimethyl-2-pyrrolidinecarboxanilide hydrochloride, but more generally known as bumecaine hydrochloride, which bears US NIH Compound Identifier 167785. Most nations, for tariff and trade purposes, schedule bumecaine hydrochloride under HS 29339990 and SITC 51577. As of Q4 2014, BUMECAINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity.

SMILES: CCCCN1CCCC1C(=O)NC2C(CC(CC2C)C)C.CL.

I cannot write this summary. The source provides only the UNSPSC code number, code name, and tier designation. It contains no recent state and local contract opportunities, no issuing-body activity, no geographic spread data, and no representative solicitations.

The <most-recent-state-local-contract-opportunities> block is empty, which means no recent posting data supports a business development summary. Without concrete procurement activity, I cannot characterize what state and local governments are actually buying under this code, which jurisdictions are soliciting, where activity is concentrated, or what representative opportunities exist.

To produce a useful summary, I need the <most-recent-state-local-contract-opportunities> block populated with actual solicitation records.